Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

W J Edmunds, G F Medley, D J Nokes, C J O'Callaghan, H C Whittle, A J Hall, W J Edmunds, G F Medley, D J Nokes, C J O'Callaghan, H C Whittle, A J Hall

Abstract

This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas. We describe the association between the prevalence of carriers and a simple measure of the rate of infection, the age at which half the population have been infected (A50), and assess the contribution of horizontal and perinatal transmission to this association. We found that the two main hyper-endemic areas of sub-Saharan Africa and east Asia have similar prevalences of carriers and values of A50, and that there is a negative nonlinear relationship between A50 and the prevalence of carriers in high endemicity areas (Spearman's Rank, P = 0.0086). We quantified the risk of perinatal transmission and the age-dependent of infection to allow a comparison between the main hyper-endemic areas. East Asia was found to have higher prevalences of HBeAg positive mothers and a greater risk of perinatal transmission from HBeAg positive mothers than sub-Saharan Africa, though the differences were not statistically significant. However, the two areas have similar magnitudes and age-dependent rates of horizontal transmission. Results of a simple compartmental model suggest that similar rates of horizontal transmission are sufficient to generate the similar patterns between A50 and the prevalences of carriers. Interrupting horizontal transmission by mass immunization is expected to have a significant, nonlinear impact on the rate of acquisition of new carriers.

References

    1. N Engl J Med. 1971 Nov 18;285(21):1157-60
    1. Scand J Infect Dis. 1971;3(2):93-101
    1. Gastroenterology. 1973 Aug;65(2):277-83
    1. N Engl J Med. 1975 Apr 10;292(15):771-4
    1. J Pediatr. 1975 Sep;87(3):360-3
    1. Am J Epidemiol. 1977 Feb;105(2):94-8
    1. Am J Med Sci. 1975 Sep-Oct;270(2):287-91
    1. Am J Dis Child. 1977 Jun;131(6):644-7
    1. Gastroenterology. 1990 Sep;99(3):805-10
    1. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):283-7
    1. Lancet. 1991 Mar 30;337(8744):747-50
    1. Rev Infect Dis. 1991 Jan-Feb;13(1):52-5
    1. Lancet. 1991 May 18;337(8751):1180-3
    1. J Infect Dis. 1992 Jun;165(6):1111-5
    1. Gastroenterology. 1992 Aug;103(2):590-4
    1. J Infect Dis. 1993 Jul;168(1):9-14
    1. Proc Biol Sci. 1993 Aug 23;253(1337):197-201
    1. J Med Virol. 1985 Aug;16(4):309-14
    1. N Z Med J. 1985 Jul 10;98(782):529-32
    1. Br Med J. 1978 Apr 15;1(6118):949-52
    1. J Infect Dis. 1978 Nov;138(5):668-71
    1. J Med Virol. 1979;3(3):237-41
    1. J Infect Dis. 1980 Mar;141(3):299-305
    1. J Pediatr. 1980 Nov;97(5):768-70
    1. Br J Obstet Gynaecol. 1980 Nov;87(11):958-65
    1. Bull World Health Organ. 1980;58(4):621-8
    1. Southeast Asian J Trop Med Public Health. 1980 Dec;11(4):582-7
    1. Am J Epidemiol. 1981 May;113(5):510-9
    1. Prog Med Virol. 1981;27:137-47
    1. Prog Med Virol. 1981;27:148-62
    1. Gut. 1981 Jun;22(6):499-504
    1. Lancet. 1981 Aug 22;2(8243):388-93
    1. Lancet. 1981 Nov 21;2(8256):1129-33
    1. J Infect Dis. 1983 Feb;147(2):360
    1. J Hyg (Lond). 1983 Apr;90(2):259-325
    1. Lancet. 1983 Nov 12;2(8359):1099-102
    1. Lancet. 1983 Nov 12;2(8359):1103-4
    1. S Afr Med J. 1983 Nov 26;64(23):891-3
    1. J Infect Dis. 1983 Dec;148(6):1122
    1. Bull World Health Organ. 1983;61(6):991-6
    1. Lancet. 1984 Apr 28;1(8383):921-6
    1. Lancet. 1984 Jun 2;1(8388):1210-2
    1. Am J Epidemiol. 1984 Oct;120(4):617-25
    1. Arch Dis Child. 1985 Jan;60(1):56-8
    1. J Infect Dis. 1985 Apr;151(4):599-603
    1. J Infect Dis. 1985 Apr;151(4):604-9
    1. J Med Virol. 1985 Feb;15(2):113-20
    1. J Med Virol. 1985 Mar;15(3):265-9
    1. J Pediatr. 1985 May;106(5):843-9
    1. Lancet. 1986 Oct 18;2(8512):919-20
    1. Lancet. 1986 Nov 15;2(8516):1143-5
    1. Am J Epidemiol. 1987 Jan;125(1):140-9
    1. J Med Virol. 1987 Feb;21(2):137-45
    1. Ann Trop Paediatr. 1986 Dec;6(4):239-41
    1. Gastroenterology. 1987 Jun;92(6):1844-50
    1. J Med Virol. 1987 May;22(1):1-5
    1. J Infect. 1987 Sep;15(2):183-8
    1. J Trop Med Hyg. 1987 Oct;90(5):249-53
    1. J Med Virol. 1988 Feb;24(2):191-7
    1. J Med Virol. 1988 Mar;24(3):343-9
    1. N Z Med J. 1988 Nov 23;101(858):788-90
    1. J Med Virol. 1988 Dec;26(4):411-8
    1. Int J Epidemiol. 1988 Dec;17(4):874-9
    1. Am J Trop Med Hyg. 1989 Feb;40(2):200-6
    1. Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S574-8
    1. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):698-700
    1. Vaccine. 1990 Mar;8 Suppl:S129-33; discussion S134-8
    1. Vaccine. 1990 Mar;8 Suppl:S74-8; discussion S79-80
    1. Arch Intern Med. 1990 May;150(5):1051-4
    1. J Infect Dis. 1990 Jun;161(6):1112-5
    1. Am J Epidemiol. 1990 Aug;132(2):220-32
    1. J Hyg (Lond). 1985 Oct;95(2):419-36
    1. Am J Epidemiol. 1986 Mar;123(3):473-80
    1. J Med Virol. 1986 Jun;19(2):135-42
    1. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814-21

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever